Bioequivalency Study of Sulindac in Capsule vs. Tablet Formulations

Mayo Clinic2 个研究点分布在 1 个国家目标入组 28 人开始时间: 2006年4月最近更新: 2015年4月28日

适应症

试验速览

阶段: 不适用
状态: 已完成
发起方: Mayo Clinic
入组人数: 28
试验地点: 2

研究概览研究设计入排标准研究者研究点记录与标识符相似试验

研究概览

简要总结

RATIONALE: Giving healthy volunteers sulindac capsules or sulindac tablets may help doctors learn which form of the drug may be more effective in preventing cancer.

PURPOSE: This randomized clinical trial is studying sulindac capsules to see how well they work compared with sulindac tablets in healthy volunteers.

详细描述

OBJECTIVES:

Primary

Compare the systemic exposure of sulindac tablets vs sulindac capsules in healthy volunteers.

Secondary

Compare the terminal half-life and time of peak drug concentration of sulindac tablets vs sulindac capsules.

研究设计

研究类型: Interventional
分配方式: Randomized
主要目的: Prevention

入排标准

年龄范围: 40 Years 至 —（Adult, Older Adult）
性别: All
接受健康志愿者: 是

入选标准

未提供

排除标准

未提供

研究者

发起方

Mayo Clinic

申办方类型

Other

研究点 (2)

Loading locations...

相似试验

已完成

不适用

Efficacy of prophylactic use of Sulindac in comparison with Ibuprofen on post-operative endodontic pai

IRCT138809222847N1Rafsanjan University of Medical Sciences48

终止

1 期

A Study of ASP8273 in Subjects With Non-small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) MutationsNon-small Cell Lung Cancer (NSCLC)Epidermal Growth Factor Receptor (EGFR) Mutations

NCT03082300Astellas Pharma Global Development, Inc.3

已完成

1 期

A Clinical Trial Looking at the Comparability of 2 Different Forms of SemaglutideHealthy Volunteers (Diabetes Mellitus, Type 2)

NCT05232708Novo Nordisk A/S18

已完成

1 期

Minocycline Bioequivalence StudySkin Diseases

NCT01938508GlaxoSmithKline28

已完成

1 期

A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (C) Semaglutide TabletsHealthy VolunteersType 2 Diabetes

NCT04109508Novo Nordisk A/S278